Harmonia MentisHarmonia Mentis

HCP Repository

  1. Home
  2. UK HCP
  3. Resources

  4. You are here: HCP Repository

Article

This webpage is intended for UK-I health care professionals.

 

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events and product complaint should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. Adverse events and product complaint should also be reported to Angelini Pharma on (UK) +44 2034889643, (IRE) +353 1 584 4671 or UKIReporting@angelinipharma.com

ⓘ Click here for Prescribing Information and Adverse Event Reporting

HCP Asset Repository

To order physical copies of these assets please email info@angelinipharma.com.

HCP Guide

This guide provides information on how to prescribe ONTOZRY® and is aimed at helping HCPs make prescribing choices.

To order physical copies of these assets please email info@angelinipharma.com.

To view the digital version of the HCP Guide please click here.

Patient Brochure

The patient brochure is aimed at providing information to patients about their new medication - ONTOZRY®.

To order physical copies of these assets please email info@angelinipharma.com.

Patient Titration Diary

This is the Patient Titration Diary that aims to aid patients with the titration process.

To order physical copies of these assets please email info@angelinipharma.com.

How to initiate a patient Leave Piece

This Leave Piece gives guidance on how best to initiate a patient on ONTOZRY®.

To order physical copies of these assets please email info@angelinipharma.com.

NICE Leave Piece

This Leave Piece aims to provide information on the NICE Guidance when prescribing ONTOZRY®.

Key Selling Messages Leaflet

This leaflet provides information on the 4 key selling messages for ONTOZRY®.

To order physical copies of these assets please email info@angelinipharma.com.

To view the KSM leaflet please click here.

Drug-Drug interactions leavepiece

This leavepiece aims to provide information about the key drug-drug interactions associated with the prescription of ONTOZRY®.

To order physical copies of these assets please email info@angelinipharma.com.

UKxxxxP | July 2023

;